Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication

被引:39
作者
Castilletti, C
Bordi, L
Lalle, E
Rozera, G
Poccia, F
Agrati, C
Abbate, I
Capobianchi, MR
机构
[1] Natl Inst Infect Dis INMI L Spallanzani, Virol Lab, I-00149 Rome, Italy
[2] Natl Inst Infect Dis INMI L Spallanzani, Immunol Lab, Rome, Italy
关键词
SARS-CoV; PBMC; fixed cell;
D O I
10.1016/j.virol.2005.07.015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Severe acute respiratory syndrome (SARS) is an emerging infection caused by a novel coronavirus known as SARS-CoV, characterized by an over-exuberant immune response with lung lymphomononuclear cells infiltration and proliferation that may account for tissue damage more than the direct effect of viral replication. This study is aimed at investigating the capability of SARS-CoV to activate IFN-alpha and -gamma expression in lymphomonocytes (PBMC) from healthy donors, evaluating whether viral replication is necessary for this activation. Results: SARS-CoV virus is able to induce both IFN-alpha and -gamma mRNA accumulation and protein release in a dose-dependent manner, MO110 being the most effective. The time course curve indicated that IFN-alpha mRNA induction peaked at 24 h.p.i,. whereas TFN-gamma mRNA was still increasing at 48 h.p.i. Released IFN (both types) reached a plateau after 24-48 h.p.i. and remained rather stable over a 5-day period. A transient peak of negative strand viral RNA was detected after 1-2 days of infection, but neither infectious virus progeny yield nor newly produced viral genomic RNA could be evidenced in infected cultures, even after prolonged observation time (up to 13 days). Cocultivation of PBMC with fixed SARS-CoV-infected Vero cells was even more efficient than exposure to live virus in eliciting IFN-alpha and -gamma induction. A combination of IFN-alpha and -gamma strongly inhibited SARS-CoV replication in Vero cells, while the single cytokines were much less effective. Conclusions: This study provides evidence that SARS-CoV is able to induce in normal PBMC a coordinate induction of IFN-alpha and -gamma gene expression. Virus replication is not necessary for IFN induction since efficient IFN expression could be obtained also by the cocultivation of normal PBMC with fixed SARS-CoV-nfected cells. Concomitant activation of IFN-alpha and -gamma gene expression by SARS-CoV in vivo may be relevant for the pathogenesis of the disease, both for the possible involvement in immunomediated damage of the tissues and for the strong inhibition of SARS-CoV replication as a result of combined cytokine action. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 20 条
  • [11] SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients
    Li, LJ
    Wo, J
    Shao, JB
    Zhu, HH
    Wu, NP
    Li, MW
    Yao, HP
    Hu, MJ
    Dennin, RH
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 28 (03) : 239 - 244
  • [12] A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection -: art. no. 34
    Ng, LF
    Hibberd, ML
    Ooi, EE
    Tang, KF
    Neo, SY
    Tan, J
    Murthy, KRK
    Vega, VB
    Chia, JM
    Liu, ET
    Ren, EC
    [J]. BMC INFECTIOUS DISEASES, 2004, 4 (1)
  • [13] Lung pathology of fatal severe acute respiratory syndrome
    Nicholls, JM
    Poon, LLM
    Lee, KC
    Ng, WF
    Lai, ST
    Leung, CY
    Chu, CM
    Hui, PK
    Mak, KL
    Lim, W
    Yan, KW
    Chan, KH
    Tsang, NC
    Guan, Y
    Yuen, KY
    Peiris, JSM
    [J]. LANCET, 2003, 361 (9371) : 1773 - 1778
  • [14] Severe acute respiratory syndrome related coronavirus is inhibited by interferon-α
    Ströher, U
    DiCaro, A
    Li, Y
    Strong, JE
    Aoki, F
    Plummer, F
    Jones, SM
    Feldmann, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) : 1164 - 1167
  • [15] A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
    Takasuka, N
    Fujii, H
    Takahashi, Y
    Kasai, M
    Morikawa, S
    Itamura, S
    Ishii, K
    Sakaguchi, M
    Ohnishi, K
    Ohshima, M
    Hashimoto, S
    Odagiri, T
    Tashiro, M
    Yoshikura, H
    Takemori, T
    Tsunetsugu-Yokota, Y
    [J]. INTERNATIONAL IMMUNOLOGY, 2004, 16 (10) : 1423 - 1430
  • [16] Severe acute respiratory syndrome and the innate immune responses: Modulation of effector cell function without productive infection
    Tseng, CTK
    Perrone, LA
    Zhu, HB
    Makino, S
    Peters, CJ
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (12) : 7977 - 7985
  • [17] Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
    Wong, CK
    Lam, CWK
    Wu, AKL
    Ip, WK
    Lee, NLS
    Chan, IHS
    Lit, LCW
    Hui, DSC
    Chan, MHM
    Chung, SSC
    Sung, JJY
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) : 95 - 103
  • [18] Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
    Wong, RSM
    Wu, A
    To, KF
    Lee, N
    Lam, CWK
    Wong, CK
    Chan, PKS
    Ng, MHL
    Yu, LM
    Hui, DS
    Tam, JS
    Cheng, G
    Sung, JJY
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7403): : 1358 - 1362
  • [19] SARS-coronavirus replication in human peripheral monocytes/macrophages
    Yilla, M
    Harcourt, BH
    Hickman, CJ
    McGrew, M
    Tamin, A
    Goldsmith, CS
    Bellini, WJ
    Anderson, LJ
    [J]. VIRUS RESEARCH, 2005, 107 (01) : 93 - 101
  • [20] 2003, CLIN MED J, V116, P1283